162 related articles for article (PubMed ID: 36538056)
1. Kidney concentrating capacity in children with autosomal recessive polycystic kidney disease is linked to glomerular filtration and hypertension.
Seeman T; Bláhová K; Fencl F; Klaus R; Lange-Sperandio B; Hrčková G; Podracká Ĺ
Pediatr Nephrol; 2023 Jul; 38(7):2093-2100. PubMed ID: 36538056
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.
Zittema D; Boertien WE; van Beek AP; Dullaart RP; Franssen CF; de Jong PE; Meijer E; Gansevoort RT
Clin J Am Soc Nephrol; 2012 Jun; 7(6):906-13. PubMed ID: 22516290
[TBL] [Abstract][Full Text] [Related]
3. The Clinical and Mutational Spectrum of 69 Turkish Children with Autosomal Recessive or Autosomal Dominant Polycystic Kidney Disease: A Multicenter Retrospective Cohort Study.
Tutal O; Gulhan B; Atayar E; Yuksel S; Ozcakar ZB; Soylemezoglu O; Saygili S; Caliskan S; Inozu M; Baskin E; Duzova A; Hayran M; Topaloglu R; Ozaltin F
Nephron; 2024; 148(5):319-332. PubMed ID: 36657418
[TBL] [Abstract][Full Text] [Related]
4. Renal concentrating capacity is linked to blood pressure in children with autosomal dominant polycystic kidney disease.
Seeman T; Dusek J; Vondrák K; Bláhová K; Simková E; Kreisinger J; Dvorák P; Kyncl M; Hríbal Z; Janda J
Physiol Res; 2004; 53(6):629-34. PubMed ID: 15588131
[TBL] [Abstract][Full Text] [Related]
5. Hypomagnesaemia is absent in children with autosomal dominant polycystic kidney disease.
Seeman T; Fořtová M; Sopko B; Průša R; Pohl M; John U
Ann Clin Biochem; 2019 Jan; 56(1):90-94. PubMed ID: 29874928
[TBL] [Abstract][Full Text] [Related]
6. Neurocognition in children with autosomal recessive polycystic kidney disease in the CKiD cohort study.
Hartung EA; Matheson M; Lande MB; Dell KM; Guay-Woodford LM; Gerson AC; Warady BA; Hooper SR; Furth SL
Pediatr Nephrol; 2014 Oct; 29(10):1957-65. PubMed ID: 24828609
[TBL] [Abstract][Full Text] [Related]
7. Hereditary polycystic kidney diseases in children: changing sonographic patterns through childhood.
Avni FE; Guissard G; Hall M; Janssen F; DeMaertelaer V; Rypens F
Pediatr Radiol; 2002 Mar; 32(3):169-74. PubMed ID: 12164348
[TBL] [Abstract][Full Text] [Related]
8. Ambulatory blood pressure and hypertension control in children with autosomal recessive polycystic kidney disease: clinical experience from two central European tertiary centres.
Seeman T; Blažík R; Fencl F; Bláhová K; Obeidová L; Štekrová J; Weigel F; John-Kroegel U
J Hypertens; 2022 Mar; 40(3):425-431. PubMed ID: 35081580
[TBL] [Abstract][Full Text] [Related]
9. Renal cyst evolution in childhood: a contemporary observational study.
Rediger C; Guerra LA; Keays MA; Wayne C; Reddy D; Ksara S; Leonard MP
J Pediatr Urol; 2019 Apr; 15(2):188.e1-188.e6. PubMed ID: 30808538
[TBL] [Abstract][Full Text] [Related]
10. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
[TBL] [Abstract][Full Text] [Related]
11. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
[TBL] [Abstract][Full Text] [Related]
12. Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.
Zittema D; Casteleijn NF; Bakker SJ; Boesten LS; Duit AA; Franssen CF; Gaillard CA; Gansevoort RT
PLoS One; 2017; 12(1):e0169263. PubMed ID: 28081165
[TBL] [Abstract][Full Text] [Related]
13. Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
Nakajima A; Lu Y; Kawano H; Horie S; Muto S
Clin Exp Nephrol; 2015 Dec; 19(6):1199-205. PubMed ID: 25715868
[TBL] [Abstract][Full Text] [Related]
14. Ambulatory pulse pressure and its contributors in autosomal dominant polycystic kidney disease.
Koska-Ścigała A; Jankowska M; Szyndler A; Narkiewicz K; Dębska-Ślizień A
Adv Clin Exp Med; 2022 May; 31(5):575-578. PubMed ID: 35543199
[TBL] [Abstract][Full Text] [Related]
15. The spectrum of polycystic kidney disease in children.
Dell KM
Adv Chronic Kidney Dis; 2011 Sep; 18(5):339-47. PubMed ID: 21896375
[TBL] [Abstract][Full Text] [Related]
16. Kidney Disease Progression in Autosomal Recessive Polycystic Kidney Disease.
Dell KM; Matheson M; Hartung EA; Warady BA; Furth SL;
J Pediatr; 2016 Apr; 171():196-201.e1. PubMed ID: 26831744
[TBL] [Abstract][Full Text] [Related]
17. Low agreement between various eGFR formulae in pediatric and young adult ADPKD patients.
Schellekens P; Verjans M; Janssens P; Dachy A; De Rechter S; Breysem L; Allegaert K; Bammens B; Vennekens R; Vermeersch P; Pottel H; Mekahli D
Pediatr Nephrol; 2023 Sep; 38(9):3043-3053. PubMed ID: 36939917
[TBL] [Abstract][Full Text] [Related]
18. Increasing prevalence of hypertension during long-term follow-up in children with autosomal dominant polycystic kidney disease.
Seeman T; Jansky P; Filip F; Bláhová K; Jaroš A
Pediatr Nephrol; 2021 Nov; 36(11):3717-3723. PubMed ID: 34008126
[TBL] [Abstract][Full Text] [Related]
19. Urine and plasma osmolality in patients with autosomal dominant polycystic kidney disease: reliable indicators of vasopressin activity and disease prognosis?
Casteleijn NF; Zittema D; Bakker SJ; Boertien WE; Gaillard CA; Meijer E; Spithoven EM; Struck J; Gansevoort RT
Am J Nephrol; 2015; 41(3):248-56. PubMed ID: 25926129
[TBL] [Abstract][Full Text] [Related]
20. Urinary citrate as a marker of renal function in patients with autosomal dominant polycystic kidney disease.
Borrego Utiel FJ; Herrera Contreras I; Merino García E; Camacho Reina MV; Moriana Domínguez C; Ocaña Pérez E
Int Urol Nephrol; 2022 Apr; 54(4):873-881. PubMed ID: 34279821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
